16.000
+0,00%
2026-10-19
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -83.6% | -29.9% | 1 / 3 | +2.5% | -6.08 pp | -8.21 pp | +9.6% | 0.19 | 7.24 | 28,5 | +2,5% | 0,4 | −83,6% | 7.24 | 5.81 | +24,7% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 16.000 (close price on 2026-10-19)EPS (TTM): 2.209
Financial charts
1.Revenue & growth
VND bn28,5Q2/26
1.Revenue & growth
VND bn28,5Q2/26
2.Profit & growth
VND bn0,45Q2/26
3.Profit mix (Penman)
VND bn9,05Q2/26
4.Margins & cost structure
%24.5%Q2/26
5.Returns & cash cycle
% · days7.5%Q2/26
6.Earnings quality & cash
VND bn1,12Q2/26
7.Asset structure
VND bn118Q2/26
8.Funding & debt health
VND bn · times118Q2/26
9.Revenue backlog
VND bn0,02Q2/26
10.Valuation
times · %7,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %147Q2/26
Adjusted EPS growth, latest quarter
-83.6%
Average adjusted EPS growth, 3 quarters
-29.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26